Redpin Therapeutics, founded by Arkin Bio, specializes in creating innovative neuromodulation therapies using chemogenetics. Redpin was acquired by Kryia Therapeutics in 2022.
Arkin Entry Stage
Discovery
Status
M&A
Location
NYC
Let’s get in touch!
